January/February 2017
Medical Benefit Specialty Drug Management–A Call to Action
February 15, 2017
Article
Features
Specialty drug trend management typically focuses on drug formulations administered via a payer or plan sponsor pharmacy benefit, which overlooks drug spending occurring under a payer or plan sponsor medical benefit.
Behavioral Analytics: Key to Shutting Down the Medicare Part D ATM
February 15, 2017
Article
Features
Advanced behavioral analytics can differentiate patterns of fraud and abuse from instances such as oncology patients receiving multiple prescriptions from different specialists.
Specialty Drugs Year in Review Part II: Oncology Drugs and Late-breaking FDA Actions
February 15, 2017
Article
Clinical Insights
A comprehensive review of new oncology molecular entities and previously approved oncology drugs that received expanded indications in 2016, as well as drugs approved in the final days of the year.
Late-Stage Pipeline Review for Multiple Sclerosis Treatments
February 14, 2017
Article
New Product Pipeline
Current stage 3 trials for multiple sclerosis medications may address several unmet needs in the patient population.
Value-based Contracting 2.0: Is Specialty Pharmacy Ready for its Shot at the Spotlight?
February 14, 2017
Article
Features
Specialty pharmacies that offer effective medication therapy management and support are best suited to serve as arbiters of the next generation of value-based contracts.
HHS Guidance Requires Specialty Pharmacies to Scrutinize Patient Cost-Sharing and Incentive Programs
February 14, 2017
Article
In Practice
Specialty pharmacies will need to carefully consider the effect of the final rule regarding Anti-Kickback Statute safe harbors and Civil Monetary Penalty Law exceptions on their existing patient benefit programs.
Should Specialty Look at Mobile Health?
February 14, 2017
Article
Viewpoints: The Last Word
With the growth of fitness apps, electronic health records, and telemedicine, mobile health is poised to enter the specialty pharmacy space.
Tweeting This Out: Build a Wall Around DIR Fees and Make Specialty Pharmacy Great Again
February 14, 2017
Article
Editorial
If direct and indirect remuneration fees are to remain, the health care system must recognize that specialty pharmacies provide different services to patients.
Specialty Pharmacy’s Role in the Changing Face of Health Care
February 14, 2017
Article
From the Chairman